The Latest Breaking News from MRK

Is Merck Stock Underperforming the Nasdaq?

Despite Merck’s recent underperformance relative to the Nasdaq, analysts remain moderately optimistic about the stock’s prospects.

Barchart · May 29, 2025

Are Wall Street Analysts Bullish on Merck Stock?

While Merck has trailed the broader market over the past year, analysts still see a reasonably promising path ahead for the pharma heavyweight.

Barchart · May 6, 2025

Do Wall Street Analysts Like Pfizer Stock?

Pfizer has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart · May 1, 2025

These S&P 500 Stocks Have Low P/E Ratios — Time to Buy?

This article covers three stocks included in the S&P 500 which are showing exceptionally low P/E ratios of 20 or less, indicating potential buys.

MarketBeat · Mar 3, 2025

Is Merck Stock Underperforming the S&P 500?

Despite Merck’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart · Feb 28, 2025

MarketBeat Week in Review – 02/10 - 02/14

Despite many negative headlines, stocks are trading near all-time highs; next week will be a shortened trading week, with most of the monthly economic data in

MarketBeat · Feb 15, 2025

Merck: 4 No-Brainer Reasons to Buy This Dip

Merck & Co. stock was pummeled by 10% after its earnings release on soft forecasts, but the overreaction by the market may present a buying opportunity.

MarketBeat · Feb 10, 2025

Stock Market Today: Earnings Speak Louder Than Tariffs

Recent market reaction to Trump administration policy announcements has been "entirely normal."

Kiplinger · Feb 4, 2025

3 High-Conviction Stocks with Strong Buy Ratings from Analysts

It’s easy to get caught up in market noise, but investing in companies backed by strong fundamentals and long-term growth potential can help investors stay the course even during market volatility. Thus, one could consider adding these three high-conviction pharmaceutical stocks, AbbVie (ABBV), Merck & Co. (MRK), and Bristol-Myers Squibb…

StockNews.com · Feb 4, 2025

What Are Wall Street Analysts’ Target Price for Merck Stock?

Merck has considerably underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart · Feb 4, 2025